# UK Extracorporeal Membrane Oxygenation Machine Market

> UK Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) andBy Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.98%
- **2024:** $ 102.5 Million
- **2025:** $ 108.63 Million
- **2035:** $ 194.2 Million
- **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Xenios AG (DE)

**Report ID:** MRFR/MED/49069-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/uk-extracorporeal-membrane-oxygenation-machine-market-50826

---

## Market Summary

## **UK Extracorporeal Membrane Oxygenation Machine Market Overview**

As per MRFR analysis, the UK Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 96.8 (USD Million) in 2023. The UK Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 102.3 (USD Million) in 2024 to 245.5 (USD Million) by 2035. The UK Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 8.283% during the forecast period (2025 - 2035).

### **Key UK Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted**

The UK Extracorporeal Membrane Oxygenation (ECMO) machine market is experiencing significant growth, driven by increasing rates of respiratory and cardiac illnesses, particularly in the wake of the COVID-19 pandemic which heightened the need for advanced life-support technologies. With the NHS recognizing the value of ECMO in critical care, there has been a concerted effort to expand the availability of these machines across hospitals, leading to enhanced patient management capabilities in severe cases.

The shift towards minimally invasive procedures and technological advancements are also strong market drivers, as healthcare facilities seek to improve recovery outcomes and patient comfort. The market presents an opportunity to capitalise on the development of portable ECMO systems, which can enable timely intervention outside of traditional hospital settings, thereby enhancing patient access and treatment efficacy.

Furthermore, the UK market has the potential to benefit from innovations that could further improve the functionality and efficacy of ECMO machines, given the ongoing research and development in artificial organs and related technologies. A growing emphasis on the training of healthcare personnel to effectively operate ECMO machines has been observed in recent trends, which is essential for the safety of patients and the efficacy of treatment.

Furthermore, the UK healthcare system is customising devices to address specific medical requirements through partnerships between hospitals and technology developers, which are influencing advancements in machine design and usability. Real-time patient monitoring and enhanced clinical decision-making are enabled by the increasing recognition of the incorporation of data analytics and monitoring systems within ECMO technologies.

The dynamic landscape of the UK ECMO machine market is collectively illustrated by these interrelated factors, which disclose both current developments and future potential with a clear horizon towards modernisation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **UK Extracorporeal Membrane Oxygenation Machine Market Drivers**

#### **Rising Incidence of Respiratory Diseases**

The UK is witnessing an alarming rise in respiratory diseases, which is one of the primary drivers for the UK [Extracorporeal Membrane Oxygenation Machine Market](../../../reports/extracorporeal-membrane-oxygenation-machine-market-8119) Industry. According to the National Health Service (NHS), the number of patients suffering from chronic respiratory diseases is projected to increase by over 15% in the next decade. This rise can be attributed to various factors, including pollution and lifestyle changes.

With the NHS considerably investing in advanced medical technologies, the demand for Extracorporeal Membrane Oxygenation Machines is expected to surge as these devices become critical in managing severe respiratory distress in patients, especially given that they can substantially reduce mortality rates in ECMO settings. The UK government's commitment to improving healthcare outcomes aligns with the growth of the market as healthcare facilities look to modernize and upgrade their treatment options.

#### **Technological Advancements in ECMO Systems**

Recent technological advancements in Extracorporeal Membrane Oxygenation (ECMO) systems have significantly contributed to the growth of the UK Extracorporeal Membrane Oxygenation Machine Market Industry. Innovative designs that offer portability and enhanced efficiency are now gaining traction in the UK healthcare sector. The National Institute for Health and Care Excellence (NICE) has advocated for the adoption of new medical technologies, estimating that integrating advanced ECMO systems can improve treatment outcomes by up to 20%.

Such advancements are attracting more hospitals to adopt these technologies, leading to a growth in demand for Extracorporeal Membrane Oxygenation Machines, especially during surgical procedures and critical care.

#### **Increase in Critical Care Units**

The expansion of critical care units across the UK is fostering growth in the UK Extracorporeal Membrane Oxygenation Machine Market Industry. The NHS has reported a significant increase in the number of Intensive Care Units (ICUs) and High Dependency Units (HDUs) in recent years, with an increase of approximately 10% in ICU capacities due to the need for better acute care facilities in response to growing patient needs.

This increased capacity necessitates the availability of advanced medical equipment like Extracorporeal Membrane Oxygenation Machines, as hospitals look to enhance their capabilities to treat critically ill patients effectively. The UK government's investment into healthcare resources directly aligns with the rising demand for these machines, thus reshaping the market landscape.

### **UK Extracorporeal Membrane Oxygenation Machine Market Segment Insights**

#### **Extracorporeal Membrane Oxygenation Machine Market Application Insights**

The UK Extracorporeal Membrane Oxygenation Machine Market, particularly in relation to the Application segment, manifests significant growth potential and diverse applications. This market encompasses key areas such as Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass, which are integral in addressing critical medical needs.

Cardiac Support is particularly essential as it aids patients suffering from severe heart conditions, facilitating circulatory assistance during surgical procedures or when heart function is compromised. On the other hand, Respiratory Support has gained prominence, especially in the context of pulmonary diseases, highlighting its importance during respiratory failure, thus improving patient outcomes and survival rates.

The Cardiopulmonary Bypass sector plays a vital role during cardiac surgeries by providing a mechanism to temporarily take over the function of the heart and lungs. This market segmentation illustrates a robust structure that aligns with the rising demand for advanced medical technologies in the UK healthcare scene.

The trend of increasing applications across these segments is underscored by advancements in technology, improved training for medical personnel, and enhancing awareness of surgical opportunities that utilize extracorporeal membrane oxygenation machines. Furthermore, the UK government’s commitment to enhancing healthcare infrastructure further propels this market's growth, as investments in healthcare result in improved facilities and access to life-saving technologies.

Increasing patient inflow, particularly in intensive care units, and a growing prevalence of cardiovascular and respiratory diseases are also fuelling this market.

The evolution of the healthcare landscape in the UK, with the integration of new methodologies to treat critical conditions, ensures that the Application aspect of the UK Extracorporeal Membrane Oxygenation Machine Market will continue to expand. The importance of specialized medical devices in treating acute cases is paramount, and the segmentation into Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass showcases the multifaceted utility of these machines in clinical settings. Each segment not only addresses specific patient needs but also enables healthcare providers to deliver timely and effective interventions, ultimately aiming towards improved patient health outcomes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

#### **Extracorporeal Membrane Oxygenation Machine Market End User Insights**

The End User landscape within the UK Extracorporeal Membrane Oxygenation Machine Market is characterized by a diverse array of platforms, predominantly including Hospitals, Ambulatory Surgical Centers, and Home Care Settings. Hospitals represent a critical segment, being densely equipped with advanced technologies and skilled healthcare professionals capable of managing complex procedures involving Extracorporeal Membrane Oxygenation.

They play a significant role in treating patients with severe respiratory or cardiac failure. Ambulatory Surgical Centers are gaining traction due to their ability to deliver cost-effective and efficient care, facilitating quicker patient recovery and discharge, which aligns with the UK healthcare system's focus on improving patient outcomes.

Meanwhile, Home Care Settings are emerging as a vital area, reflecting a growing trend towards patient-centric care models, where patients benefit from treatment in the comfort of their own homes, significantly enhancing their quality of life while reducing the strain on hospital resources. Collectively, these segments illustrate a comprehensive approach to patient care, reinforcing the UK’s commitment to advancing healthcare delivery mechanisms across various environments.

This dynamic interplay within the End User sector is expected to significantly contribute to the overall growth and evolution of the UK Extracorporeal Membrane Oxygenation Machine Market.

#### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights**

The UK Extracorporeal Membrane Oxygenation Machine Market emphasizes several product types, specifically Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO, each serving distinct clinical needs within the healthcare system. Venoarterial ECMO is particularly essential for providing cardiopulmonary support during cardiac arrest or severe respiratory failure, making it crucial in critical care settings. Venovenous ECMO, alternatively, focuses on patients with severe lung dysfunction, allowing for adequate oxygenation while minimizing the effects on the cardiovascular system.

This type has seen substantial adoption due to its effectiveness in treating conditions like ARDS (Acute Respiratory Distress Syndrome). Arteriovenous ECMO plays a vital but more niche role, primarily applied in specific scenarios requiring direct blood oxygenation and purification. The going trend highlights a growing demand for advanced ECMO systems that can improve patient outcomes while reducing the burden on healthcare facilities. Rising awareness of ECMO benefits and advancements in technology are key drivers influencing the market, creating opportunities for providing better care to patients, thereby impacting the overall UK healthcare landscape positively.

#### **Extracorporeal Membrane Oxygenation Machine Market Component Insights**

The UK Extracorporeal Membrane Oxygenation Machine Market is experiencing notable growth driven by advancements in technology and a rising demand for effective life-supporting devices in critical care settings. Within the Component segment, the Membrane Oxygenator plays a crucial role, as it allows for efficient gas exchange, proving essential for patients with severe respiratory or cardiac conditions. Blood Pumps are equally significant, facilitating blood circulation and ensuring patient stability during extracorporeal procedures.

Heat Exchangers, while often overlooked, are critical in maintaining optimal blood temperature, thereby supporting patient metabolism during therapy. With increasing cases of cardiovascular diseases in the UK, these components are gaining prominence as healthcare providers enhance their clinical capabilities. The market segmentation reflects the diverse applications within extracorporeal membrane oxygenation systems, and each of these elements is pivotal in offering comprehensive care solutions, ultimately contributing to improved patient outcomes in healthcare settings across the UK. The ongoing integration of innovative technology further amplifies the importance of these components in the evolving landscape of the UK Extracorporeal Membrane Oxygenation Machine Market.

### **UK Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights**

The UK Extracorporeal Membrane Oxygenation (ECMO) Machine Market has experienced a significant growth trajectory in recent years, driven by advancements in medical technology, increased awareness of the benefits of ECMO therapies, and rising cases of respiratory and cardiac failures that necessitate the use of this life-support system. The competitive landscape is characterized by a diverse array of players, ranging from established medical device manufacturers to emerging biotech firms. Companies are striving to enhance their product offerings and technological capabilities by focusing on innovation and responding to the specific needs of healthcare providers.

This has led to a competitive environment where factors such as product reliability, ease of use, regulatory compliance, and customer service play crucial roles in determining market success. Additionally, collaborations, partnerships, and mergers in this sector have become common strategies for firms aiming to strengthen their market position and expand their reach within the UK healthcare ecosystem.

Cameron Health has established a solid footing in the UK ECMO market, primarily through its commitment to delivering high-quality products that meet rigorous industry standards. The company's strengths lie in its advanced technology and a user-friendly design that allows healthcare professionals to operate ECMO machines efficiently. With a focus on patient safety and operational reliability, Cameron Health has built a reputation among healthcare providers who prioritize outcomes and care quality. Their engagement with hospitals to tailor ECMO solutions to local requirements has enhanced their visibility and relevance in the UK market.

Furthermore, Cameron Health's dedication to ongoing training and support for medical personnel has contributed to its competitive edge, fostering trust and ensuring that users make the most of its advanced technology in critical care settings.

Fresenius Medical Care enjoys a prominent presence in the UK Extracorporeal Membrane Oxygenation Machine Market, primarily due to its extensive portfolio of renal care and critical care products, which includes well-designed ECMO systems. The company has a robust footprint in the market supported by its commitment to research and development, enabling it to deliver cutting-edge solutions to healthcare professionals. Fresenius Medical Care's key products in the ECMO segment are designed to enhance patient mobility while ensuring optimal oxygenation, which is vital in critical care situations.

Its strengths lie not only in product innovation but also in strategic partnerships with healthcare facilities aimed at improving clinical outcomes. Moreover, the company has engaged in various mergers and acquisitions, bolstering its market positioning and expanding its operational capabilities within the UK. This proactive approach to growth combined with a focus on high-quality service delivery makes Fresenius Medical Care a formidable player in the UK ECMO market landscape.

#### **Key Companies in the UK Extracorporeal Membrane Oxygenation Machine Market Include**

### **UK Extracorporeal Membrane Oxygenation Machine Market Industry Developments**

Recent developments in the UK Extracorporeal Membrane Oxygenation (ECMO) Machine Market indicate a growing emphasis on advanced technologies and patient care solutions. Companies such as Fresenius Medical Care and Getinge are making strides in innovating ECMO support systems, enhancing both efficiency and patient outcomes. In October 2023, Medtronic launched an initiative focused on R&D for a next-generation ECMO device that aims to minimize complications associated with traditional systems. Additionally, notable mergers and acquisitions have occurred; for example, in September 2023, LivaNova acquired a smaller company specializing in ECMO technology, expanding its product portfolio and market reach.

The UK market is experiencing significant growth as reflected in its increasing market valuation, primarily driven by a rise in respiratory diseases and an aging population. Over the past few years, Edwards Lifesciences and ZOLL Medical Corporation have made substantial contributions to the market, resulting in enhanced collaboration among major players. Noteworthy strides in governmental healthcare initiatives to fund advanced ECMO training for healthcare professionals further underline the commitment to improving critical care in the UK.

### **UK Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights**

#### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook**

#### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook**

#### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook**

#### **Extracorporeal Membrane Oxygenation Machine Market Component Outlook**

## Market Drivers

### Increased Focus on Emergency Preparedness

The increased focus on emergency preparedness within the UK healthcare system is driving the extracorporeal membrane-oxygenation-machine market. As healthcare facilities prepare for various emergencies, including natural disasters and mass casualty incidents, the need for effective life-support systems becomes paramount. Extracorporeal membrane-oxygenation machines are recognized for their critical role in providing respiratory and cardiac support during such events. This heightened awareness has led to strategic planning and investment in essential medical equipment. Consequently, healthcare institutions are more likely to incorporate these machines into their emergency response protocols, thereby boosting the demand for extracorporeal membrane-oxygenation machines. This trend reflects a broader commitment to enhancing the resilience of the healthcare system.

### Technological Innovations in Medical Devices

Technological innovations in medical devices are significantly influencing the extracorporeal membrane-oxygenation-machine market. Continuous advancements in technology, such as miniaturization and improved biocompatibility of materials, enhance the performance and usability of these machines. The introduction of smart monitoring systems and automated features allows for better patient management and outcomes. As hospitals in the UK seek to adopt cutting-edge technologies, the demand for state-of-the-art extracorporeal membrane-oxygenation machines is expected to rise. Furthermore, these innovations may lead to cost reductions in long-term patient care, making them more appealing to healthcare providers. The ongoing research and development in this field suggest a promising future for the market.

### Increasing Prevalence of Respiratory Diseases

The rising incidence of respiratory diseases in the UK is a crucial driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia necessitate advanced respiratory support systems. According to recent health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to an increased demand for extracorporeal membrane-oxygenation machines. This trend is likely to continue as the population ages and the prevalence of such diseases rises. The healthcare sector is thus compelled to invest in advanced technologies to enhance patient outcomes, which in turn propels the growth of the extracorporeal membrane-oxygenation-machine market. Furthermore, the integration of these machines into standard treatment protocols may become more common, further solidifying their role in critical care settings.

### Rising Investment in Healthcare Infrastructure

The UK government has been increasing its investment in healthcare infrastructure, which serves as a significant driver for the extracorporeal membrane-oxygenation-machine market. Enhanced funding for hospitals and healthcare facilities allows for the procurement of advanced medical equipment, including extracorporeal membrane-oxygenation machines. Recent budgets indicate a commitment to improving critical care services, which is essential for managing severe respiratory and cardiac conditions. This investment not only facilitates the acquisition of new technologies but also supports the training of healthcare professionals in their use. As a result, the demand for extracorporeal membrane-oxygenation machines is expected to rise, reflecting the broader trend of enhancing patient care through improved healthcare infrastructure.

### Growing Awareness of Advanced Treatment Options

There is a notable increase in awareness regarding advanced treatment options among healthcare providers and patients in the UK. This growing awareness is a key driver for the extracorporeal membrane-oxygenation-machine market. Medical professionals are increasingly recognizing the benefits of extracorporeal membrane-oxygenation as a life-saving intervention for patients with severe respiratory or cardiac failure. Educational initiatives and clinical guidelines are promoting the use of these machines, leading to a higher adoption rate in critical care units. As healthcare providers become more informed about the capabilities and advantages of extracorporeal membrane-oxygenation machines, the market is likely to experience substantial growth. This trend indicates a shift towards more aggressive treatment strategies in critical care settings.

## Future Outlook

The [Extracorporeal Membrane Oxygenation Machine Market](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119) is projected to grow at a 5.98% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands.

**New opportunities:**

- Development of portable ECMO devices for home care settings.
- Integration of AI for predictive analytics in patient management.
- Expansion of training programs for ECMO specialists in hospitals.

By 2035, the market is expected to achieve substantial growth, reflecting enhanced healthcare capabilities.

## Segment Insights

### By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing)

In the UK extracorporeal membrane-oxygenation-machine market, the distribution of market share among the application segments reveals that Cardiac Support holds the largest share. This segment's prominence can be attributed to the increasing prevalence of cardiovascular diseases and the rising number of surgical procedures, driving demand for advanced cardiac support solutions. In contrast, Respiratory Support, while smaller in market share, is witnessing rapid growth due to the upswing in respiratory conditions and the rising usage of ECMO in critical care settings.

Growth trends within this segment are significantly influenced by technological advancements and increasing clinical applications of ECMO devices. The growing awareness regarding the benefits of these machines and their effectiveness in managing severe respiratory distress further enhances the uptake. Additionally, the ongoing innovations in design and functionality are attracting more healthcare providers to integrate ECMO in their treatment protocols, indicating sustained growth in the coming years.

Cardiac Support (Dominant) vs. Respiratory Support (Emerging)

Cardiac Support has established itself as the dominant application within the UK extracorporeal membrane-oxygenation-machine market, characterized by its critical role in managing severe cardiac conditions. The efficiency and effectiveness of ECMO devices in providing life-sustaining support during cardiac surgeries and failures underline their market position. Conversely, Respiratory Support is identified as an emerging segment, rapidly gaining traction due to an increase in its applications in treating a variety of respiratory ailments. The enhanced capabilities of ECMO systems in addressing acute respiratory failure scenarios affirm its growing role, supported by expanding clinical adoption and a rising number of patients requiring advanced respiratory care.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the UK extracorporeal membrane-oxygenation-machine market, hospitals dominate the end user segment, accounting for a significant share of market utilization. This robust market presence is driven by the high demand for ECMO machines in critical care settings, facilitating complex treatments and surgical procedures. On the other hand, ambulatory surgical centers have emerged as a fast-growing segment as they increasingly adopt ECMO technology to enhance patient care in less invasive settings.

Growth trends for the end user segment reflect an increasing emphasis on advanced respiratory support solutions, particularly in hospital settings, where the need for effective oxygenation during critical medical procedures is paramount. Furthermore, the expansion of ambulatory surgical centers is fueled by advancements in medical technology and a shift toward outpatient procedures, highlighting the flexibility and efficiency of ECMO systems across diverse healthcare environments.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent the dominant end user in the UK extracorporeal membrane-oxygenation-machine market due to their established infrastructure and comprehensive critical care capabilities. With specialized intensive care units and a high patient volume for severe respiratory conditions, hospitals rely heavily on ECMO machines for lifesaving interventions. Conversely, ambulatory surgical centers are an emerging segment that provides a growing alternative to traditional hospitals. They are increasingly equipping themselves with ECMO technologies, driven by the demand for quicker, outpatient procedures. This shift not only enhances patient access to vital respiratory support but also allows these centers to capitalize on technological advancements, making them a key player in the evolution of ECMO utilization.

### By Product Type: Venoarterial ECMO (Largest) vs. Venovenous ECMO (Fastest-Growing)

In the UK extracorporeal membrane-oxygenation-machine market, Venoarterial ECMO currently holds the largest share among the product types, driven by its critical application in supporting patients with severe cardiac issues. Venovenous ECMO, while smaller in market share, showcases significant growth potential and is rapidly gaining traction due to its versatile application in respiratory support. Both segments reflect the expanding clinical need for advanced life-support technologies that cater to diverse patient conditions.

The growth trends of these segment values indicate a clear trajectory towards increased adoption of ECMO technologies in critical care settings. Driving factors include advancements in technology, improved patient outcomes through innovative treatments, and the rising incidence of cardiac and respiratory diseases. Healthcare providers are increasingly recognizing the benefits of ECMO, contributing to a more robust market outlook. Furthermore, ongoing research and clinical trials are expected to further propel the market, particularly enhancing the appeal of Venovenous ECMO among medical institutions.

Venoarterial ECMO (Dominant) vs. Venovenous ECMO (Emerging)

Venoarterial ECMO is regarded as the dominant product type within the UK extracorporeal membrane-oxygenation-machine market, primarily utilized for patients with cardiac failure or shock. This ECMO type effectively facilitates both cardiac and respiratory support, making it essential in critical situations. In contrast, Venovenous ECMO is emerging rapidly, primarily used for respiratory failure, appealing to healthcare systems due to its effectiveness in less invasive procedures. As the medical community embraces innovations in ECMO technology, these products are expected to evolve, with Venovenous ECMO gaining ground as clinicians recognize its adaptability and growing role in critical care management.

### By Component: Membrane Oxygenator (Largest) vs. Blood Pumps (Fastest-Growing)

In the UK extracorporeal membrane-oxygenation-machine market, the Membrane Oxygenator segment commands the largest market share, reflecting its critical role in effective patient management during ECMO procedures. Blood Pumps follow closely, securing a significant portion of the market, while Heat Exchangers hold a smaller share but are essential for maintaining optimal conditions during treatment. The distribution indicates a well-established reliance on membrane technology, combined with a growing interest in advanced pump solutions.

Growth trends indicate a rapid increase in the adoption of innovative Blood Pumps, driven by advancements in technology and their ability to enhance patient outcomes. The demand for efficient and reliable ECMO systems fuels the market, with a shift towards integrating smart technologies for better monitoring and control. Membrane Oxygenators remain vital, but the emerging Blood Pump technology is set to reshape healthcare approaches and treatment efficiency.

Membrane Oxygenator (Dominant) vs. Blood Pumps (Emerging)

The Membrane Oxygenator stands out as the dominant component in the UK extracorporeal membrane-oxygenation-machine market, recognized for its pivotal function in gas exchange during ECMO procedures. Its established presence is complemented by continuous innovations aimed at enhancing efficiency and patient safety. Conversely, Blood Pumps are emerging as a significant force within the market, propelled by technological advancements that improve their performance and reliability. These pumps have become increasingly sophisticated, offering features that ensure the precise delivery of blood while minimizing complications. Their growing adoption signifies a pivotal shift in the landscape, with healthcare providers seeking more effective solutions to support critically ill patients.

## Competitive Benchmarking

The extracorporeal membrane-oxygenation-machine market exhibits a dynamic competitive landscape, characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Medtronic (US) focuses on integrating advanced technologies into its ECMO systems, aiming to improve patient outcomes and operational efficiency. Getinge (SE) emphasizes sustainability and [digital transformation](https://www.marketresearchfuture.com/reports/digital-transformation-market-8685), aligning its product offerings with the increasing demand for eco-friendly medical devices. LivaNova (GB) is strategically positioned through its commitment to research and development, fostering collaborations that enhance its product portfolio and market reach.
The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the current economic climate. The collective influence of these major companies shapes a competitive environment where innovation and operational efficiency are paramount. As companies adapt to changing market demands, their strategies reflect a broader trend towards enhancing service delivery and patient care.
In October 2025, Medtronic (US) announced a partnership with a leading UK hospital to pilot a new ECMO system designed to streamline patient management and reduce recovery times. This collaboration underscores Medtronic's commitment to innovation and its strategic focus on enhancing clinical outcomes through advanced technology. The pilot program is expected to provide valuable insights into the system's efficacy, potentially influencing future product development.
In September 2025, Getinge (SE) launched a new line of ECMO machines that incorporate AI-driven analytics to monitor patient conditions in real-time. This strategic move not only positions Getinge as a leader in [digital health](https://www.marketresearchfuture.com/reports/digital-healthcare-market-7636)solutions but also reflects the growing trend of integrating artificial intelligence into medical devices. The ability to leverage data for improved patient monitoring could significantly enhance treatment protocols and outcomes.
In August 2025, LivaNova (GB) expanded its product offerings by acquiring a smaller firm specializing in innovative ECMO technologies. This acquisition is indicative of LivaNova's strategy to bolster its R&D capabilities and diversify its product range. By integrating new technologies, LivaNova aims to enhance its competitive edge and respond more effectively to the evolving needs of healthcare providers.
As of November 2025, the competitive trends in the extracorporeal membrane-oxygenation-machine market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, supply chain reliability, and enhanced patient care solutions. This shift suggests that companies prioritizing innovation and operational excellence will be better positioned to thrive in this rapidly changing market.

## Recent News & Developments

Recent developments in the UK Extracorporeal Membrane Oxygenation (ECMO) Machine Market indicate a growing emphasis on advanced technologies and patient care solutions. Companies such as Fresenius Medical Care and Getinge are making strides in innovating ECMO support systems, enhancing both efficiency and patient outcomes. In October 2023, Medtronic launched an initiative focused on R&D for a next-generation ECMO device that aims to minimize complications associated with traditional systems. Additionally, notable mergers and acquisitions have occurred; for example, in September 2023, LivaNova acquired a smaller company specializing in ECMO technology, expanding its product portfolio and market reach.

The UK market is experiencing significant growth as reflected in its increasing market valuation, primarily driven by a rise in respiratory diseases and an aging population. Over the past few years, Edwards Lifesciences and ZOLL Medical Corporation have made substantial contributions to the market, resulting in enhanced collaboration among major players. Noteworthy strides in governmental healthcare initiatives to fund advanced ECMO training for healthcare professionals further underline the commitment to improving critical care in the UK.

## Report Scope

| MARKET SIZE 2024 | 102.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 108.63(USD Million) |
| MARKET SIZE 2035 | 194.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.98% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Xenios AG (DE) |
| Segments Covered | Application, End User, Product Type, Component |
| Key Market Opportunities | Advancements in technology and regulatory support enhance growth potential in the extracorporeal membrane-oxygenation-machine market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the extracorporeal membrane-oxygenation-machine market. |
| Countries Covered | UK |

## Frequently Asked Questions

**Q: What was the market valuation of the UK extracorporeal membrane-oxygenation-machine market in 2024?**
A: The market valuation was $102.5 Million in 2024.

**Q: What is the projected market valuation for the UK extracorporeal membrane-oxygenation-machine market by 2035?**
A: The projected valuation for 2035 is $194.2 Million.

**Q: What is the expected CAGR for the UK extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 5.98%.

**Q: Which application segment had the highest valuation in 2024?**
A: The Respiratory Support application segment had the highest valuation at $40.0 Million.

**Q: What is the projected valuation for the Cardiac Support application segment by 2035?**
A: The projected valuation for the Cardiac Support application segment is $56.0 Million by 2035.

**Q: Which end user segment is expected to grow the most by 2035?**
A: The Hospitals end user segment is expected to grow to $76.5 Million by 2035.

**Q: What was the valuation of the Venovenous ECMO product type in 2024?**
A: The Venovenous ECMO product type had a valuation of $40.0 Million in 2024.

**Q: Which component segment is projected to have the highest valuation by 2035?**
A: The Membrane Oxygenator component segment is projected to reach $75.0 Million by 2035.

**Q: Who are the key players in the UK extracorporeal membrane-oxygenation-machine market?**
A: Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Xenios AG.

**Q: What was the valuation of the Home Care Settings end user segment in 2024?**
A: The Home Care Settings end user segment had a valuation of $32.0 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-extracorporeal-membrane-oxygenation-machine-market-50826*